Home » Business, News & Current Affairs, Pharmaceuticals & Biotech, Science, Technology » Bioabsorbable Stents Market worth 2.4 Billion USD by 2021
The report “Bioabsorbable Stents Market Material (Polymer, Metal), Procedure (Invasive), Absorption Rate (Slow, Fast), Drugs (Limus drugs, Paclitaxel), Application (CAD, PAD), End User (Hospital, Cardiac Centers) – Forecast to 2021”, analyzes and studies the major market drivers, restraints, opportunities, and challenges in Europe, North America, Asia, and the Rest of the World (RoW).

Browse 88 market data tables with 43 figures spread through 126 pages and in-depth TOC on “Bioabsorbable Stents Market Material (Polymer, Metal), Procedure (Invasive), Absorption Rate (Slow, Fast), Drugs (Limus drugs, Paclitaxel), Application (CAD, PAD), End User (Hospital, Cardiac Centers) – Forecast to 2021” 

http://www.marketsandmarkets.com/Market-Reports/bioabsorbable-stent-market-40983380.html

Early buyers will receive 10% customization on reports.

The global bioabsorbable stents market is expected to reach USD 2.4 Billion by 2021 from USD 0.4 Billion by 2016, at a CAGR of 42.5% during the forecast period.

The major driving factors are the increasing focus of the companies on clinical trials of bioabsorbable stents, increasing aging population, technological advancements, and patients’ preference for minimally invasive therapies. However, factors such as the high prices of these stents may hamper the growth of the market.

In this report, the bioabsorbable stents market is segmented on the basis of Material, absorption rate, application, end user, and region. Based on material, the market is segmented into polymer stents, and metallic stents. The polymer stents segment is expected to grow at the highest CAGR due to the various facts such as polymer-based bioabsorbable stents comprise PLLA polymers that are naturally biodegradable. These stents have a polymer coating of poly-D,L-lactide, which enables the controlled release of various drugs.

Request Free Sample Pages @ http://www.marketsandmarkets.com/requestsample.asp?id=40983380

By absorption rate, the market is sub-segmented into fast and slow bioabsorbable stents. In 2016, slow absorbable stents is expected to account for the largest share of the absorption rate. The growth in this segment is attributed to slow rate of absorption enables the longer duration of drug release within the arteries. This ensures efficient healing.

Geographically, the bioabsorbable stents market is dominated by Europe, followed by North America. North American market is expected to grow at the highest CAGR of 46.1% during the forecast period. This growth can be attributed to due to the increase in aging population, unhealthy lifestyle habits, and the strong healthcare infrastructure in this market.

The bioabsorbable stent market has fewer numbers of players.

Prominent players in the market include Abbott (U.S.), Elixir Medical Corporation (U.S.), Kyoto Medical Co. LTD. (Japan), Reva Medical Inc. (U.S.), Arterial Remodeling Technologies (France), Tepha Inc. (U.S.), Meril Life Sciences Pvt. Ltd. (India) among others.

Media Contact
Company Name: MarketsandMarkets
Contact Person: Mr. Rohan
Email: sales@marketsandmarkets.com
Phone: 1-888-600-6441
Country: United States
Website: http://www.marketsandmarkets.com/

Comments are closed.